Evidence map›Paper›PMID 41476520›Full record

ArticleACS omega2025

Acetylene Acetogenin from

Dalete Christine S Souza, Ivanildo A Brito, Emerson A Oliveira, Rayssa A Cajás, Thainá R Teixeira, Josué de Moraes, João Henrique G Lago

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dalete Christine S SouzaFederal University of ABC, Center for Natural and Human Sciences, Av. dos Estados, 5001, 09210-180 Santo André, SP, Brazil.
Ivanildo A BritoFederal University of ABC, Center for Natural and Human Sciences, Av. dos Estados, 5001, 09210-180 Santo André, SP, Brazil.
Emerson A OliveiraFederal University of ABC, Center for Natural and Human Sciences, Av. dos Estados, 5001, 09210-180 Santo André, SP, Brazil.
Rayssa A CajásGuarulhos University, Center for Research on Neglected Diseases, Praça Tereza Cristina, 88, 07023-070 Guarulhos, SP, Brazil.
Thainá R TeixeiraGuarulhos University, Center for Research on Neglected Diseases, Praça Tereza Cristina, 88, 07023-070 Guarulhos, SP, Brazil.
Josué de MoraesGuarulhos University, Center for Research on Neglected Diseases, Praça Tereza Cristina, 88, 07023-070 Guarulhos, SP, Brazil.ORCID https://orcid.org/0000-0003-1766-7031
João Henrique G LagoFederal University of ABC, Center for Natural and Human Sciences, Av. dos Estados, 5001, 09210-180 Santo André, SP, Brazil.ORCID https://orcid.org/0000-0002-1193-8374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis affects nearly 250 million people, primarily in low-income regions. Aligned with the Sustainable Development Goals, the WHO roadmap highlights the urgent need for new therapeutic alternatives to praziquantel, the only available drug for schistosomiasis treatment. Natural products, including γ-lactones from Annonaceae species, have shown promising anthelmintic activity. The present work aimed to investigate the anthelmintic potential of the natural acetogenin 3-hydroxy-4-methylene-2-(

Identifiers

PMID41476520
PMCPMC12750220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.